Epi-trichosetin, a new undecaprenyl pyrophosphate synthase inhibitor, produced by Fusarium oxysporum FKI-4553

Journal of Antibiotics

Volumn 66, Issue 9, 2013, Pages 549-554

  Inokoshi, Junji ^a   Shigeta, Naoki ^a   Fukuda, Takashi ^a   Uchida, Ryuji ^a   Nonaka, Kenichi ^a   Masuma, Rokurou ^a   Tomoda, Hiroshi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

epi trichosetin; Fusarium oxysporum FKI 4553; Undecaprenyl pyrophosphate synthase inhibitor

Indexed keywords

ENZYME INHIBITOR; EPI TRICHOSETIN; FARNESYL TRANS TRANSFERASE; TRICHOSETIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CARBON NUCLEAR MAGNETIC RESONANCE; CHLAMYDOSPORE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; ENZYME INHIBITION; FUNGAL STRAIN; FUSARIUM OXYSPORUM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HETERONUCLEAR MULTIPLE QUANTUM COHERENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORPHOLOGICAL TRAIT; MYCOPLASMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLVENT EXTRACTION; STAPHYLOCOCCUS AUREUS; STEREOISOMERISM; YEAST;

ALKYL AND ARYL TRANSFERASES; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; ENZYME INHIBITORS; FUSARIUM; GRAM-POSITIVE BACTERIA; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PYRROLIDINONES; SEQUENCE ANALYSIS, DNA; SPECTRUM ANALYSIS; STAPHYLOCOCCUS AUREUS;

EID: 84885014488     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2013.44     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention (CDC). Staphylococcus aureus with reduced susceptibility to vancomycin-United States. Morb. Mortal. Wkly. Rep 46, 765-766 (1997
2. Hiramatsu, K. et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40, 135-136 (1997
3. Fowler, V. G. Jr et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355, 653-665 (2006
4. Irinoda, K., Nomura, S. & Hashimoto, M. Antimicrobial and clinical effect of linezolid (ZYVOX), new class of synthetic antibacterial drug. Nihon. Yakurigaku. zasshi. 120, 245-252 (2002) in Japanese
5. Walsh, C. T. Antibiotics: Actions, Origins, Resistance (ASM Press, Washington, DC, 2003
6. Inokoshi, J. et al. Spirohexalines, new inhibitors of bacterial undecaprenyl pyrophosphate synthase, produced by Penicillium brasilianum FKI-3368. J. Antibiot. 66, 37-41 (2013
7. Marfori, E. C., Kajiyama, S., Fukusaki, E. & Kobayashi, A Trichosetin, a novel tetramic acid antibiotic produced in dual culture of Trichoderma harzianum and Catharanthus roseus callus. Z Naturforsch C 57, 465-470 (2002
8. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403-410 (1990
9. Dictionary of Natural Products on DVD December 2011, Version 20.2. (Chapman & Hall, CRC Press, London, 2011
10. Vazquez, M. J., Rodriguez, B., Zapatero, C. & Tew, D. G. Determination of phosphate in nanomolar range by an enzyme-coupling fluorescent method. Anal. Biochem. 320, 292-298 (2003
11. Vesonder, R. F., Tjarks, L. W., Rohwedder, W. K., Burmeister, H. R. & Laugal, J. A Equisetin, an antibiotic from Fusarium equiseti NRRL 5537, identified as a derivative of N-methyl-2,4-pyrollidone. J. Antibiot. 32, 759-761 (1979
12. Lang, G., Blunt, J. W., Cummings, N. J., Cole, A. L. & Munro, M. H. Paecilosetin, a new bioactive fungal metabolite from a New Zealand isolate of Paecilomyces farinosus. J. Nat. Prod. 68, 810-811 (2005
13. Singh, S. et al. Equisetin and a novel opposite stereochemical homolog phomasetin, two fungal metabolites as inhibitors of HIV-1 integrase. Tetrahedron Lett. 39, 2243-2246 (1998
14. Sugie, Y. et al. CJ-21,058, a new SecA inhibitor isolated from a fungus. J. Antibiot. (Tokyo) 55, 25-29 (2002
15. Marfori, E. C., Kajiyama, S., Fukusaki, E. & Kobayashi, A. Phytotoxicity of the tetramic acid metabolite trichosetin. Phytochemistry 62, 715-721 (2003
16. Hazuda, D. et al. Isolation and characterization of novel human immunodeficiency virus integrase inhibitors from fungal metabolites. Antivir. Chem. Chemother. 10, 63-70 (1999
17. De Clercq, E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med. Res. Rev. 20, 323-349 (2000
18. Ogura, K. & Koyama, T. Enzymatic aspects of isoprenoid chain elongation. Chem. Rev. 98, 1263-1276 (1998
19. Phillips, N. J., Goodwin, J. T., Fraiman, A., Cole, R. J. & Lynn, D. G. Characterization of the fusarium toxin equisetin: The use of phenylbronates in structure assignment. J. Am. Chem. Soc. 111, 8223-8231 (1989
20. Marfori, E. C., Banba, M., Kajiyama, S., Fukusaki, E. & Kobayashi, A. Biosynthetic studies of the tetramic acid antibiotic trichosetin. Tetrahedron 58, 6655-6658 (2002
21. Stickings, C. E. & Townsend, R. J. Studies in the biochemistry micro-organisms. Biochem. J. 78, 412-418 (1961
22. Kornerup, A. & Wanscher, J. H. Methuen Handbook of Colour. 3rd edn (Eyre Methuen, London, 1978
23. White, T. J., Bruns, T., Lee, S. & Taylor, J. In: PCR Protocols: A Guide to Methods and Applications (eds Innis, M. A., Gelfand, D. H., Sninsky, J. J. & White, T. J.) (Academic Press, New York 315-322, 1990
24. Fukuda, T., Matsumoto, A., Takahashi, Y., Tomoda, H. & Omura, S. Phenatic acids A and B, new potentiators of antifungal miconazole activity produced by Streptomyces sp. K03-0132. J. Antibiot. 58, 252-259 (2005